Charles Schwab
NUVA

Charles Schwab’s NuVasive, Inc. NUVA Stock Holding History

Charles Schwab’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-564,392
Closed -$23.5M – 3680
2023
Q2 		$23.5M Buy
564,392
+2,643
+0.5% +$109K 0.01% 1384
2023
Q1 		$23.2M Sell
561,749
-91,865
-14% -$3.93M 0.01% 1348
2022
Q4 		$27M Buy
653,614
+63,098
+11% +$2.55M 0.01% 1212
2022
Q3 		$25.9M Buy
590,516
+86,111
+17% +$4.17M 0.01% 1193
2022
Q2 		$24.8M Buy
504,405
+11,338
+2% +$608K 0.01% 1234
2022
Q1 		$28M Buy
493,067
+18,634
+4% +$990K 0.01% 1279
2021
Q4 		$24.9M Buy
474,433
+15,341
+3% +$834K 0.01% 1401
2021
Q3 		$27.5M Buy
459,092
+15,806
+4% +$975K 0.01% 1306
2021
Q2 		$30M Buy
443,286
+19,601
+5% +$1.34M 0.01% 1249
2021
Q1 		$27.8M Buy
423,685
+244
+0.1% +$14.6K 0.01% 1249
2020
Q4 		$23.9M Buy
423,441
+11,761
+3% +$578K 0.01% 1273
2020
Q3 		$20M Sell
411,680
-73,081
-15% -$3.94M 0.01% 1202
2020
Q2 		$27M Buy
484,761
+6,061
+1% +$351K 0.01% 970
2020
Q1 		$24.3M Buy
478,700
+76,835
+19% +$5.15M 0.01% 888
2019
Q4 		$31.1M Buy
401,865
+6,085
+2% +$430K 0.02% 921
2019
Q3 		$25.1M Buy
395,780
+29,737
+8% +$1.86M 0.01% 993
2019
Q2 		$21.4M Buy
366,043
+2,343
+0.6% +$138K 0.01% 1087
2019
Q1 		$20.7M Buy
363,700
+22,095
+6% +$1.17M 0.01% 1081
2018
Q4 		$16.9M Buy
341,605
+1,696
+0.5% +$102K 0.01% 1105
2018
Q3 		$24.1M Buy
339,909
+18,710
+6% +$1.19M 0.02% 1024
2018
Q2 		$16.7M Buy
321,199
+33,351
+12% +$1.75M 0.01% 1229
2018
Q1 		$15M Buy
287,848
+9,136
+3% +$463K 0.01% 1195
2017
Q4 		$16.3M Buy
278,712
+20,686
+8% +$1.17M 0.01% 1135
2017
Q3 		$14.3M Buy
258,026
+23,482
+10% +$1.55M 0.01% 1165
2017
Q2 		$18M Buy
234,544
+23,280
+11% +$1.74M 0.02% 937
2017
Q1 		$15.8M Buy
211,264
+13,102
+7% +$951K 0.02% 980
2016
Q4 		$13.3M Buy
198,162
+12,667
+7% +$817K 0.01% 1052
2016
Q3 		$12.4M Buy
185,495
+8,766
+5% +$558K 0.01% 1010
2016
Q2 		$10.6M Buy
176,729
+8,518
+5% +$460K 0.01% 1026
2016
Q1 		$8.18M Buy
168,211
+4,924
+3% +$223K 0.01% 1177
2015
Q4 		$8.84M Buy
163,287
+12,853
+9% +$655K 0.01% 1106
2015
Q3 		$7.25M Sell
150,434
-19,036
-11% -$984K 0.01% 1197
2015
Q2 		$8.03M Sell
169,470
-135,024
-44% -$6.31M 0.01% 1202
2015
Q1 		$14M Buy
304,494
+14,872
+5% +$691K 0.02% 769
2014
Q4 		$13.7M Sell
289,622
-16,581
-5% -$691K 0.02% 697
2014
Q3 		$10.7M Buy
306,203
+2,844
+0.9% +$101K 0.02% 770
2014
Q2 		$10.8M Buy
303,359
+2,606
+0.9% +$89.2K 0.02% 768
2014
Q1 		$11.6M Sell
300,753
-8,395
-3% -$308K 0.02% 701
2013
Q4 		$9.99M Sell
309,148
-11,737
-4% -$353K 0.02% 723
2013
Q3 		$7.99M Buy
320,885
+3,837
+1% +$94.4K 0.02% 781
2013
Q2 		$7.95M Buy
+317,048
New +$6.94M 0.02% 688

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Charles Schwab's NUVA Position: Q3 2023 in Review

Charles Schwab sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 564,392 shares — an estimated $23.5M sold.

Charles Schwab first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $31.1M in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Charles Schwab reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 564,392 NuVasive, Inc. shares in Q3 2023, an estimated $23.5M.
  • Charles Schwab first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Charles Schwab's NuVasive, Inc. position peaked at $31.1M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.